Bombshell Oxford Study
Less than 6% of “Approved” Medical Drugs Are Backed by “High-Quality Evidence” to Support Their Benefits – “Harms” are Significantly Underreported Across the Board
According to a newly released study by the University of Oxford, a jaw-dropping 94% of recently approved medications are not supported by high-quality evidence that demonstrates their benefits. What’s more, just like with the experimental Covid-19 ‘vaccines,’ side effects and adverse reactions to these drugs are being severely underreported across the board.
When looking at medical drugs that have been approved since 2008 under the Cochrane reviews – a “leading” international journal and database that is endorsed by over 100 organizations worldwide, including the US Food and Drug Administration (FDA) -researchers determined that just 87 of the 1,567 medications (6%) had clinical data that met the “high-quality” standard.
From the Oxford study:
“Of 1567 eligible interventions, 87 (5.6%) had high quality evidence on first-listed primary outcomes, positive, statistically significant results and were rated by review authors as beneficial.”